Literature DB >> 11678777

Pharmacogenetics and pharmacogenomics.

M Pirmohamed.   

Abstract

Mesh：

Year:  2001        PMID： 11678777      PMCID： PMC2014592          DOI： 10.1046/j.0306-5251.2001.01498.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  18 in total

Review 1.  Pharmacogenomics: translating functional genomics into rational therapeutics.

Authors:  W E Evans; M V Relling
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

Review 2.  Science, medicine, and the future: Pharmacogenetics.

Authors:  C R Wolf; G Smith; R L Smith
Journal:  BMJ       Date:  2000-04-08

Review 3.  Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?

Authors:  D W Nebert
Journal:  Clin Genet       Date:  1999-10       Impact factor: 4.438

Review 4.  Pharmacogenetics and adverse drug reactions.

Authors:  U A Meyer
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

Review 5.  Single nucleotide polymorphisms as tools in human genetics.

Authors:  I C Gray; D A Campbell; N K Spurr
Journal:  Hum Mol Genet       Date:  2000-10       Impact factor: 6.150

6.  Drug reactions enzymes, and biochemical genetics.

Authors:  A G MOTULSKY
Journal:  J Am Med Assoc       Date:  1957-10-19

7.  Enzymatic deficiency in primaquine-sensitive erythrocytes.

Authors:  A S ALVING; P E CARSON; C L FLANAGAN; C E ICKES
Journal:  Science       Date:  1956-09-14       Impact factor: 47.728

8.  A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms.

Authors:  R Sachidanandam; D Weissman; S C Schmidt; J M Kakol; L D Stein; G Marth; S Sherry; J C Mullikin; B J Mortimore; D L Willey; S E Hunt; C G Cole; P C Coggill; C M Rice; Z Ning; J Rogers; D R Bentley; P Y Kwok; E R Mardis; R T Yeh; B Schultz; L Cook; R Davenport; M Dante; L Fulton; L Hillier; R H Waterston; J D McPherson; B Gilman; S Schaffner; W J Van Etten; D Reich; J Higgins; M J Daly; B Blumenstiel; J Baldwin; N Stange-Thomann; M C Zody; L Linton; E S Lander; D Altshuler
Journal:  Nature       Date:  2001-02-15       Impact factor: 49.962

9.  Defective N-oxidation of sparteine in man: a new pharmacogenetic defect.

Authors:  M Eichelbaum; N Spannbrucker; B Steincke; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

10.  Characterization of the common genetic defect in humans deficient in debrisoquine metabolism.

Authors:  F J Gonzalez; R C Skoda; S Kimura; M Umeno; U M Zanger; D W Nebert; H V Gelboin; J P Hardwick; U A Meyer
Journal:  Nature       Date:  1988-02-04       Impact factor: 49.962
View more
  34 in total

1.  Knowledge of Pharmacogenetics among Healthcare Professionals and Faculty Members of Health Training Institutions in Ghana.

Authors:  W Kudzi; B S Addy; B Dzudzor
Journal:  Ghana Med J       Date:  2015-03

2.  Testing patients to allow tailored drug treatment.

Authors:  Peter Leman; Shaun Greene
Journal:  BMJ       Date:  2005-02-12

Review 3.  Pharmacogenomics of the human ABC transporter ABCG2: from functional evaluation to drug molecular design.

Authors:  Toshihisa Ishikawa; Ai Tamura; Hikaru Saito; Kanako Wakabayashi; Hiroshi Nakagawa
Journal:  Naturwissenschaften       Date:  2005-10

Review 4.  The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.

Authors:  Jose de Leon; Margaret T Susce; Elaina Murray-Carmichael
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

5.  Developing products for personalized medicine: NIH Research Tools Policy applications.

Authors:  Ranjan Gupta; Jp Kim; Jack Spiegel; Steven M Ferguson
Journal:  Per Med       Date:  2004-12-01       Impact factor: 2.512

Review 6.  Single-Subject Studies in Translational Nutrition Research.

Authors:  Nicholas J Schork; Laura H Goetz
Journal:  Annu Rev Nutr       Date:  2017-07-17       Impact factor: 11.848

Review 7.  The Role of Next-Generation Sequencing in Pharmacogenetics and Pharmacogenomics.

Authors:  Ute I Schwarz; Markus Gulilat; Richard B Kim
Journal:  Cold Spring Harb Perspect Med       Date:  2019-02-01       Impact factor: 6.915

8.  Exploring Biologic Predictors Response Disparities to Atypical Antipsychotics among Blacks: A Quasi-Systematic Review.

Authors:  Rebecca N Jerome; Jill M Pulley; Nila A Sathe; Shanthi Krishnaswami; Alyssa B Dickerson; Katherine J Worley; Consuelo H Wilkins
Journal:  Ethn Dis       Date:  2020-04-02       Impact factor: 1.847

9.  Risk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of "edge effect" and cultivating an ethical bridge between omics innovations and society.

Authors:  Vural Ozdemir; Guilherme Suarez-Kurtz; Raphaëlle Stenne; Andrew A Somogyi; Toshiyuki Someya; S Oğuz Kayaalp; Eugene Kolker
Journal:  OMICS       Date:  2009-02

Review 10.  Polymorphism induced sensitivity to warfarin: a review of the literature.

Authors:  Michael P Palkimas; Hillary M Skinner; Pritesh J Gandhi; Alice J Gardner
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.